Lab Directors Should Follow cfDNA Testing Progress in Ongoing Study
AMP Annual Meeting attendees showed strong interest in the blood test
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
AMP Annual Meeting attendees showed strong interest in the blood test
Savara’s ClearPath assay needs just a few drops of blood to test for aPAP, a condition that can be difficult and invasive to diagnose
Digital and computational pathology expert Donal O’Shea explores the role of emerging technologies in addressing workforce shortages
Studies by Paige demonstrate the greater accuracy that artificial intelligence potentially offers for pathologists
The pandemic may have set the stage for a jump in infections from these four nemeses
Roche experts discuss the company’s recently launched automated solution and how it will bring mass spec to more patients
The PCR-driven test provides results in about 20 minutes in non-laboratory settings
The assays were developed with the CDC as part of recent trend of public-private partnerships to improve pandemic preparedness
On-demand testing doesn’t require registration, billing, or scheduling, keeping costs low while collecting “real” dollars upfront
At-home testing is giving patients an increasingly active role in managing their health—but what does this trend mean for labs?
The value of lab test utilization management—and the ASCP’s latest best practice recommendations for effective test utilization